Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients-Reference-Cited by-同舟云学术

Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients

Published:2013-03 Issue:3 Volume:24 Page:625-632
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bertucci F.,Finetti P.,Roche H.,Le Doussal J.M.,Marisa L.,Martin A.L.,Lacroix-Triki M.,Blanc-Fournier C.,Jacquemier J.,Peyro-Saint-Paul H.,Viens P.,Sotiriou C.,Birnbaum D.,Penault-Llorca F.

Funder

PHRC

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/3/625/13788887/mds510.pdf

Reference49 articles.

1. Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years;Bloom;Br J Cancer,1957

2. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up;Elston;Histopathology,1991

3. Prognostic significance of Nottingham histologic grade in invasive breast carcinoma;Rakha;J Clin Oncol,2008

4. Breast cancer prognostic classification in the molecular era: the role of histological grade;Rakha;Breast Cancer Res,2010

5. Problems in histological grading of malignancy and its clinical significance in patients with operable breast cancer;Komaki;Breast Cancer,2006

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel curcumin derivatives N17 exert anti-cancer effects through the CSNK1G3/AKT axis in triple-negative breast cancer;Biochemical Pharmacology;2024-11

2. Lessons from other fields of medicine, Part 1: Breast cancer;Precision Medicine in Neurodegenerative Disorders, Part I;2023

3. Utility of Genomic Platforms in Treatment Decisions in Axilla-Positive Breast Cancer;Clinical Breast Cancer;2022-10

4. Sous-types moléculaires de cancers du sein : quels enjeux pour faire évoluer le dépistage en France;Imagerie de la Femme;2021-03

5. Development of a Prognostic Tool to Guide the Decision to Extend Adjuvant Aromatase Inhibitors for up to Ten Years in Postmenopausal Early Breast Cancer Patients;Cancers;2020-12-11